Bellevue Group’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $159M | Sell |
|
|||||
|
2022
Q3 | $106M | Sell |
|
|||||
|
2022
Q2 | $73.6M | Buy |
|
|||||
|
2022
Q1 | $78M | Sell |
|
|||||
|
2021
Q4 | $96.1M | Buy |
|
|||||
|
2021
Q3 | $129M | Buy |
|
|||||
|
2021
Q2 | $120M | Buy |
|
|||||
|
2021
Q1 | $107M | Buy |
|
|||||
|
2020
Q4 | $133M | Sell |
|
|||||
|
2020
Q3 | $71.5M | Buy |
|
|||||
|
2020
Q2 | $95.8M | Sell |
|
|||||
|
2020
Q1 | $36.4M | Hold |
|
|||||
|
2019
Q4 | $74.7M | Hold |
|
|||||
|
2019
Q3 | $25M | Buy |
|
|||||
|
2019
Q2 | $35.4M | Buy |
|